A detailed history of Simplex Trading, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 7,056 shares of NUVB stock, worth $16,863. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,056
Holding current value
$16,863
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$2.58 - $3.69 $18,204 - $26,036
7,056 New
7,056 $20,000
Q2 2023

Aug 04, 2023

BUY
$1.56 - $1.84 $28 - $33
18 New
18 $0
Q2 2022

Aug 03, 2022

SELL
$3.24 - $5.85 $4,947 - $8,932
-1,527 Reduced 83.58%
300 $0
Q2 2021

Aug 12, 2021

BUY
$9.22 - $14.48 $16,844 - $26,454
1,827 New
1,827 $17,000

Others Institutions Holding NUVB

About Nuvation Bio Inc.


  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $519M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.